Bradycardia: Difference between revisions
No edit summary |
No edit summary |
||
Line 57: | Line 57: | ||
*[[Barbiturates]] | *[[Barbiturates]] | ||
*[[Beta-blockers]] | *[[Beta-blockers]] | ||
*[[Brucellosis]] | |||
*[[Bupivacaine]] | *[[Bupivacaine]] | ||
*[[Calcium channel blocker]] | *[[Calcium channel blocker]] | ||
Line 65: | Line 66: | ||
*[[Cerebral Hemorrhage]] | *[[Cerebral Hemorrhage]] | ||
*[[Cerebral venous sinus thrombosis]] | *[[Cerebral venous sinus thrombosis]] | ||
*[[ | *[[Chagas' disease]] | ||
*[[Clomipramine]] | *[[Clomipramine]] | ||
*[[Colorado tick fever]] | |||
*[[Congenital Long QT Syndrome]] | *[[Congenital Long QT Syndrome]] | ||
*[[Cushing reaction]] | *[[Cushing reaction]] | ||
Line 80: | Line 82: | ||
*[[Emery-Dreifuss muscular dystrophy]] | *[[Emery-Dreifuss muscular dystrophy]] | ||
*[[Enema]] | *[[Enema]] | ||
*[[Fetal distress]] | *[[Fetal distress]] | ||
*[[Gamma-Hydroxybutyric acid]] | *[[Gamma-Hydroxybutyric acid]] | ||
Line 97: | Line 98: | ||
*[[Hypothyroidism]] | *[[Hypothyroidism]] | ||
*[[Ibuprofen]] | *[[Ibuprofen]] | ||
*[[Isosorbide dinitrate]] | *[[Isosorbide dinitrate]] | ||
*[[Ivabradine]] | *[[Ivabradine]] | ||
*[[Legionella pneumonia and Mycoplasma pneumonia]] | |||
*[[Levobetaxolol]] | *[[Levobetaxolol]] | ||
*[[Levobupivacaine]] | *[[Levobupivacaine]] | ||
Line 135: | Line 136: | ||
*[[Pulseless ventricular tachycardia]] | *[[Pulseless ventricular tachycardia]] | ||
*[[Quinidine]] | *[[Quinidine]] | ||
*[[Raised Intracranial pressure]] | |||
*[[Rapid sequence induction]] | *[[Rapid sequence induction]] | ||
*[[Reserpine]] | *[[Reserpine]] | ||
Line 152: | Line 154: | ||
*[[Trazodone]] | *[[Trazodone]] | ||
*[[Trypanosoma cruzi]] | *[[Trypanosoma cruzi]] | ||
*[[Tularaemia]] | |||
*[[Typhoid fever]] | *[[Typhoid fever]] | ||
*[[Uncaria tomentosa]] | *[[Uncaria tomentosa]] | ||
Line 167: | Line 170: | ||
{|style="width:80%; height:100px" border="1" | {|style="width:80%; height:100px" border="1" | ||
|style="height:100px"; style="width:25%" border="1" bgcolor="LightSteelBlue" | '''Cardiovascular''' | |style="height:100px"; style="width:25%" border="1" bgcolor="LightSteelBlue" | '''Cardiovascular''' | ||
|style="height:100px"; style="width:75%" border="1" bgcolor="Beige" | | |style="height:100px"; style="width:75%" border="1" bgcolor="Beige" | [[Atrioventricular Block]],[[Cardiac arrhythmia]], | ||
[[Cardiac Dysrhythmias]], | |||
[[Cardiomegaly]], | |||
[[Right Bundle Branch Block]], | |||
[[Second Degree AV Block]], | |||
[[ST Elevation Myocardial Infarction Complications]], | |||
[[Sinoatrial Block]], | |||
[[Pulseless ventricular tachycardia]], | |||
[[Sick sinus syndrome]], | |||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 179: | Line 192: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Drug Side Effect''' | | '''Drug Side Effect''' | ||
|bgcolor="Beige"| [[Aceclidine]], | |bgcolor="Beige"| | ||
[[Aceclidine]], | |||
[[Acepromazine]], | [[Acepromazine]], | ||
[[Acetylcholinesterase inhibitor]], | [[Acetylcholinesterase inhibitor]], | ||
[[Adenosine]], | [[Adenosine]], | ||
[[Amiodarone]], | [[Amiodarone]], | ||
[[ | [[Amodiaquine]], | ||
[[Atenolol]], | [[Atenolol]], | ||
[[Barbiturates]], | [[Barbiturates]], | ||
Line 233: | Line 247: | ||
[[Timolol]], | [[Timolol]], | ||
[[Trazodone]], | [[Trazodone]], | ||
[[Uncaria tomentosa]], | |||
[[Xylazine]], | [[Xylazine]], | ||
Line 242: | Line 257: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Endocrine''' | | '''Endocrine''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Hypothyroidism]], | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Environmental''' | | '''Environmental''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Grayanotoxin]], | ||
[[Hellebore]], | |||
[[Hypothermia]], | |||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 254: | Line 275: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Genetic''' | | '''Genetic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Congenital Long QT Syndrome]], | ||
[[Catecholaminergic polymorphic ventricular tachycardia]], | |||
[[Emery-Dreifuss muscular dystrophy]], | |||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 262: | Line 287: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Iatrogenic''' | | '''Iatrogenic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| | ||
[[Enema]], | |||
[[Gastric lavage]], | |||
[[PCI Complications: Radiocontrast toxicity]], | |||
[[Rapid sequence induction]], | |||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Infectious Disease''' | | '''Infectious Disease''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Chagas' disease]], | ||
[[Hantavirus pulmonary syndrome]], | |||
[[Legionella pneumonia and Mycoplasma pneumonia]], | |||
[[Tularaemia]], | |||
[[Colorado tick fever]], | |||
[[Brucellosis]], | |||
[[Trypanosoma cruzi]], | |||
[[Typhoid fever]], | |||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Musculoskeletal / Ortho''' | | '''Musculoskeletal / Ortho''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Holt-Oram syndrome]], | ||
[[Vertebral subluxation]], | |||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Neurologic''' | | '''Neurologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Vasovagal syncope]], | ||
[[Vagal episode]], | |||
[[Neurogenic shock]], | |||
[[Subarachanoid hemorrhage]], | |||
[[Raised Intracranial pressure]], | |||
[[Autonomic neuropathy]], | |||
[[Cerebral hemorrhage]], | |||
[[Cerebral venous sinus thrombosis]], | |||
[[Cushing triad]], | |||
[[Cushing reaction]], | |||
[[Cushing reflex]], | |||
[[Neurocardiogenic Syncope]], | |||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Nutritional / Metabolic''' | | '''Nutritional / Metabolic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Hypercalcemia]], | ||
[[Hyperkalemia]], | |||
[[Hypokalemia]], | |||
[[Anorexia Nervosa]], | |||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Obstetric/Gynecologic''' | | '''Obstetric/Gynecologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Fetal distress]], | ||
[[Neonatal lupus erythematosus]], | |||
[[Vasa previa]], | |||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 290: | Line 362: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Opthalmologic''' | | '''Opthalmologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Oculocardiac reflex]], | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Overdose / Toxicity''' | | '''Overdose / Toxicity''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Gamma-Hydroxybutyric acid]], | ||
[[Hydroxyethyl starch]] | |||
[[Speedball (drug)]], | |||
[[Theobromine poisoning]], | |||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Psychiatric''' | | '''Psychiatric''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Anorexia Nervosa]], | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Pulmonary''' | | '''Pulmonary''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Apnea of prematurity]], | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 326: | Line 405: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Miscellaneous''' | | '''Miscellaneous''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Drowning]], | ||
[[Mammalian diving reflex]], | |||
|- | |- | ||
|} | |} |
Revision as of 20:17, 24 April 2009
Bradycardia | |
ICD-10 | R00.1 |
---|---|
ICD-9 | 427.81, 659.7, 785.9, 779.81 |
WikiDoc Resources for Bradycardia |
Articles |
---|
Most recent articles on Bradycardia Most cited articles on Bradycardia |
Media |
Powerpoint slides on Bradycardia |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Bradycardia at Clinical Trials.gov Clinical Trials on Bradycardia at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Bradycardia
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Bradycardia Discussion groups on Bradycardia Patient Handouts on Bradycardia Directions to Hospitals Treating Bradycardia Risk calculators and risk factors for Bradycardia
|
Healthcare Provider Resources |
Causes & Risk Factors for Bradycardia |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Cardiology Network |
Discuss Bradycardia further in the WikiDoc Cardiology Network |
Adult Congenital |
---|
Biomarkers |
Cardiac Rehabilitation |
Congestive Heart Failure |
CT Angiography |
Echocardiography |
Electrophysiology |
Cardiology General |
Genetics |
Health Economics |
Hypertension |
Interventional Cardiology |
MRI |
Nuclear Cardiology |
Peripheral Arterial Disease |
Prevention |
Public Policy |
Pulmonary Embolism |
Stable Angina |
Valvular Heart Disease |
Vascular Medicine |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Bradycardia, as applied to adult medicine, is defined as a resting heart rate of under 60 beats per minute, though it is seldom symptomatic until the rate drops below 50 beat/min. [1] Trained athletes tend to have slow resting heart rates, and resting bradycardia in athletes should not be considered abnormal if the individual has no symptoms associated with it.
The term relative bradycardia is used to explain a heart rate that, while not technically below 60 beats per minute, is considered too slow for the individual's current medical condition.
This cardiac arrhythmia can be underlain by several causes, which are best divided into cardiac and non-cardiac causes. Non-cardiac causes are usually secondary, and can involve drug use or abuse; metabolic or endocrine issues, especially in the thyroid; an electrolyte imbalance; neurologic factors; autonomic reflexes; situational factors such as prolonged bed rest; and autoimmunity. Cardiac causes include acute or chronic ischemic heart disease, vascular heart disease, valvular heart disease, or degenerative primary electrical disease. Ultimately, the causes act by three mechanisms: depressed automaticity of the heart, conduction block, or escape pacemakers and rhythms.
Causes
There are generally two types of problems that result in bradycardias: disorders of the sinus node, and disorders of the atrioventricular node (AV node).
With sinus node dysfunction (sometimes called sick sinus syndrome), there may be disordered automaticity or impaired conduction of the impulse from the sinus node into the surrounding atrial tissue (an "exit block"). It is difficult and sometimes impossible to assign a mechanism to any particular bradycardia, but the underlying mechanism is not clinically relevant to treatment, which is the same in both cases of sick sinus syndrome: a permanent pacemaker.
Atrioventricular conduction disturbances (aka: AV block; 1o AV block, 2o type I AV block, 2o type II AV block, 3o AV block) may result from impaired conduction in the AV node, or anywhere below it, such as in the bundle of HIS.
Patients with bradycardia have likely acquired it, as opposed to having it congenitally. Bradycardia is more common in older patients.
Complete Differential Diagnosis of the Causes of Bradycardia
(In alphabetical order)
- Aceclidine
- Acepromazine
- Acetylcholinesterase inhibitor
- Adenosine
- Amiodarone
- Amodiaquine
- Anorexia Nervosa
- Apnea of prematurity
- Atenolol
- Atrioventricular Block
- Autonomic neuropathy
- Barbiturates
- Beta-blockers
- Brucellosis
- Bupivacaine
- Calcium channel blocker
- Cardiac arrhythmia
- Cardiac Dysrhythmias
- Cardiomegaly
- Catecholaminergic polymorphic ventricular tachycardia
- Cerebral Hemorrhage
- Cerebral venous sinus thrombosis
- Chagas' disease
- Clomipramine
- Colorado tick fever
- Congenital Long QT Syndrome
- Cushing reaction
- Cushing reflex
- Cushing's triad
- Detomidine
- Digitalis
- Diltiazem
- Diphenhydramine
- Donepezil
- Doxepin
- Drowning
- Emery-Dreifuss muscular dystrophy
- Enema
- Fetal distress
- Gamma-Hydroxybutyric acid
- Gastric lavage
- Glyceryl trinitrate
- Grayanotoxin
- Hantavirus pulmonary syndrome
- Hellebore
- Holt-Oram syndrome
- Hydrocodone
- Hydroxyethyl starch
- Hypercalcemia
- Hyperkalemia
- Hypokalemia
- Hypothermia
- Hypothyroidism
- Ibuprofen
- Isosorbide dinitrate
- Ivabradine
- Legionella pneumonia and Mycoplasma pneumonia
- Levobetaxolol
- Levobupivacaine
- Lidocaine
- Lithium
- Mammalian diving reflex
- Medetomidine
- Mefloquine
- Mepivacaine
- Methacholine
- Methoxamine
- Methyldopa
- Morphine
- Moxonidine
- Myxedema coma
- Nadolol
- Nalbuphine
- Nalmefene
- Neonatal lupus erythematosus
- Neostigmine
- Nesiritide
- Neurocardiogenic Syncope
- Neurogenic shock
- Norepinephrine
- Oculocardiac reflex
- Opioid
- Oxymorphone
- PCI Complications: Radiocontrast toxicity
- Phenobarbital
- Phenylephrine
- Phenytoin
- Pilocarpine
- Propafenone
- Propranolol
- Pulseless ventricular tachycardia
- Quinidine
- Raised Intracranial pressure
- Rapid sequence induction
- Reserpine
- Right Bundle Branch Block
- Ropivacaine
- Second Degree AV Block
- Sick sinus syndrome
- Sinoatrial Block
- Speedball (drug)
- ST Elevation Myocardial Infarction Complications
- Subarachnoid hemorrhage
- Sulpiride
- Suxamethonium chloride
- Tacrine
- Theobromine poisoning
- Timolol
- Trazodone
- Trypanosoma cruzi
- Tularaemia
- Typhoid fever
- Uncaria tomentosa
- Vagal episode
- Vasa previa
- Vasovagal syncope
- Vertebral subluxation
- Xylazine
Complete Differential Diagnosis of the Causes of Bradycardia
(By organ system)
Management
There are two main reasons for treating any cardiac arrhythmias. With bradycardia, the first is to address the associated symptoms, such as fatigue, limitations on how much an individual can physically exert, fainting (syncope), dizziness or lightheadedness, or other vague and non-specific symptoms. The other reason to treat bradycardia is if the person's ultimate outcome (prognosis) will be changed or impacted by the bradycardia. Treatment in this vein depends on whether any symptoms are present, and what the underlying cause is. Primary or idiopathic bradycardia is treated symptomatically if it is significant, and the underlying cause is treated if the bradycardia is secondary.
Treatment
Drug treatment for bradycardia is typically not indicated for patients who are asymptomatic. In symptomatic patients, underlying electrolyte or acid-base disorders or hypoxia should be corrected first. IV atropine may provide temporary improvement in symptomatic patients, although its use should be balanced by an appreciation of the increase in myocardial oxygen demand this agent causes.
Atropine 0.5-1 mg IV or ET q3-5min up to 3 mg total (0.04 mg/kg)
See also
References
- ↑ Sinus Bradycardia eMedicine
Template:Skin and subcutaneous tissue symptoms and signs Template:Nervous and musculoskeletal system symptoms and signs Template:Urinary system symptoms and signs Template:Cognition, perception, emotional state and behaviour symptoms and signs Template:Speech and voice symptoms and signs Template:General symptoms and signs
de:Bradykardie it:Bradicardia nl:Bradycardie nn:Bradykardi sk:Bradykardia sv:Bradykardi